NIH-funded research R21 grant

Point-of-care RH risk tool for refeeding in anorexia nervosa

Official title: Development and testing of a point-of-care risk assessment model for refeeding hypophosphatemia in anorexia nervosa

Funded at University of Rochester · NIH-11451994 · Data updated 2026-11-12

A quick, clinician-friendly risk tool helps predict who with anorexia nervosa might develop dangerous low phosphorus during hospitalization, guiding safer feeding and monitoring.

More Anorexia Nervosa research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startSeptember 18, 2026
Project endSeptember 8, 2028
Funding year2026
Award (this year)$475,198
NIH project number1R21HD120816-01A1
Project IDNIH-11451994 on NIH RePORTER

Who could benefit from this research

Could help

Patients with anorexia nervosa admitted for medical stabilization who are at risk for refeeding syndrome.

Less likely to help

Patients who do not require medical hospitalization or who have no risk factors for refeeding hypophosphatemia may not benefit from this tool.

What this research studies

This project aims to create a practical, easy-to-use predictor that uses patient data from electronic health records to identify anorexia nervosa patients at risk for refeeding hypophosphatemia. It combines retrospective and prospective data analyses to build a clinician-facing tool that signals who needs closer monitoring or tailored nutrition plans. By making risk clearer at the bedside, the goal is to reduce complications, shorten hospital stays, and lower costs while improving patient care. The work focuses on translating data into a usable risk score that clinicians can apply during admission and treatment planning.

Why it matters

Potential benefit: If successful, clinicians will have a bedside tool to personalize nutrition and monitoring, potentially reducing refeeding complications and improving outcomes.

How similar studies have gone: Previous research supports risk-based approaches, but this project aims to provide a specifically tailored, clinician-facing predictive tool for RH in AN.

Where this research is happening

  • University of Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Kells, Meredith — University of Rochester
  • Study coordinator: Kells, Meredith

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.